Jan 13 2025
The report, conducted by WiseGuy Reports, highlights the industry’s projected expansion from $24.6 billion in 2024 to a staggering $73.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 14.68% during the forecast period. In 2023, the market was valued at $21.45 billion.
The marijuana market’s expansion is attributed to several key factors:
Continue reading
Jan 13 2025
The order, tied to the potential rescheduling of marijuana, was filed under DEA Docket No. 1362 and stems from the government’s submission of a compact disc (CD) containing public comments instead of providing the required hard copies, as mandated by a prehearing ruling. Judge Mulrooney emphasized that the government’s actions were “not a mistake borne of misunderstanding or inadvertence” but a deliberate defiance of clear instructions. The tribunal had explicitly denied the government’s earlier request to file electronic copies, citing a lack of good cause.
Continue reading
Jan 13 2025
The hearing is set for January 15 at 8 a.m. in the House Committee on Labor & Workplace Standards, a necessary step before the committee can vote on the measure.
Introduced by State Representatives Lillian Ortiz-Self and Mary Fossee on December 30, HB 1141 seeks to extend collective bargaining rights to workers involved in marijuana cultivation and processing. The bill outlines guidelines for organizing labor unions, resolving disputes, and safeguarding employees’ rights to collective bargaining.
Continue reading
Jan 13 2025
House Bill 1067 will be discussed by the House Committee on Consumer Protection & Business and members of the public on January 17 at 8 am. The bill proposes transferring licensing and regulatory authority for marijuana production, processing, and testing from the Liquor and Cannabis Board to the Department of Agriculture. This follows a previous legislative change in 2024, which moved oversight of marijuana testing labs to the Department of Agriculture, effective July 1 of that year.
The legislation outlines a comprehensive plan to shift all duties, records, and resources related to marijuana licensing to the Department of Agriculture by July 1, 2026. It ensures that existing rules, contracts, and obligations will remain valid throughout the transition.
Continue reading
Jan 13 2025
Members of the public can submit formal comment starting today, January 13, on draft rules that will complete the regulatory framework for Minnesota’s new cannabis industry. A copy of the proposed rules has been published in the State Register and may be viewed by clicking here.
The public can submit comments through the Office of Administrative Hearings (OAH) website until 4:30 p.m. on Wednesday, Feb. 12. Instructions on how to use the system are available on the OAH website.
Continue reading
Jan 13 2025
The hearing will take place on Thursday, January 16, at 8:30 a.m. in Room 422 of the Business, Labor, and Economic Affairs Committee. The resolution, if passed, would officially express Montana’s support for approving the SAFER Banking Act, which would allow banks and other financial institutions to provide financial services to state-legal marijuana businesses. This would allow state-licensed marijuana stores to move away from a dangerous cash-only model, while also giving them access to other traditional banking services such as loans and lines of credit.
Montana’s U.S. Senators, Steve Daines and Jon Tester, have both sponsored the SAFER Banking Act. The proposal was given bipartisan support by the Senate Committee on Banking, Housing, and Urban Affairs in September 2023, but failed to receive a vote of the full Senate.
Continue reading
Jan 13 2025
The bill, backed by eight cosponsors, has been referred to the Senate Health & Long-Term Care Committee for further consideration.
If enacted, the legislation would establish a regulated framework allowing licensed facilitators to administer psilocybin in controlled, supervised settings. The proposed program is modeled after Oregon’s pioneering psilocybin therapy law and aims to provide a pathway for individuals seeking treatment for mental health conditions like depression, anxiety, and PTSD.
Continue reading
Jan 13 2025
Brian Cuban, the younger brother of entrepreneur Mark Cuban, “brings a unique combination of personal recovery experience and professional advocacy to the effort”, according to a CBIH press release. A graduate of Penn State University and The University of Pittsburgh School of Law, Mr. Cuban has been a vocal champion for individuals battling addiction, mental health challenges, and societal stigma.
According to CBUH, Mr. Cuban has established himself as a thought leader in the mental health space, authoring the best-selling book The Addicted Lawyer: Tales of The Bar, Booze, Blow & Redemption and captivating audiences across North America as a keynote speaker. His work has been featured in esteemed publications such as The New York Times, CNN.com, and The Huffington Post. His most recent release, Body Brokers, sheds light on the dark and exploitative practices within the addiction recovery industry, exposing unethical behaviors that prey on vulnerable individuals seeking treatment.
Continue reading
Jan 13 2025
For the study, researchers from Jiamusi University, Tianjin First Central Hospital, and Nankai University in China investigated the effects of CBD on in an animal model, utilizing various techniques such as enzyme-linked immunosorbent assay (ELISA), quantitative reverse transcription polymerase-chain reaction (qRT-PCR), Western blot, and immunofluorescence. They also conducted cell-level experiments by transfecting si-RNA into CCD-18Co cells.
The study found that CBD significantly alleviated intestinal inflammation by upregulating nuclear factor erythroid 2-related factor 2 (Nrf2) expression and suppressing the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κb) pathway. This regulation reduced the release of inflammatory mediators, including IL-6, IL-1β, and TNF-α. Additionally, CBD demonstrated antioxidant properties by modulating the Nrf2/Heme Oxygenase-1 (HO-1) pathway and enhancing HO-1 activity.
Continue reading
Jan 13 2025
According to an analysis by The Marijuana Herald, which utilized data from state regulatory agencies and the research firm Headset, legal marijuana states sold $23.2 billion in product throughout 2024, with California and Michigan leading in sales.
The combined total for 2024 includes data from 20 of the 24 legal marijuana states. Delaware and Minnesota were excluded because their legal marijuana markets are not set to launch until later this year. Data for Virginia was also excluded, as it is the only legal marijuana state without licensed sales. Additionally, Alaska’s sales data was not included because the state has yet to release its 2024 figures, nor has Headset or any other research firm deemed reliable enough for inclusion.